PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 10, 2008European Journal of Cardio-Thoracic Surgery137 citations

Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials

View Full Paper
SWStewart R. WalshTTTjun Yip TangPKPeter Kullar

Key Result

Ischaemic preconditioning during cardiac surgery significantly reduced ventricular arrhythmias (OR 0.11; 95% CI 0.04-0.29; p=0.001), inotrope requirements, and intensive care unit stay.

Study Design

Type

Meta-Analysis (n=933)

Structured PICO

Does ischaemic preconditioning improve perioperative clinical outcomes in patients undergoing cardiac surgery?

P
Population
933 patients across 22 trials undergoing on-pump cardiac surgery.
I
Intervention
Ischaemic preconditioning (IP) performed mainly after initiation of cardiopulmonary bypass, before any additional myocardial protection was initiated
C
Comparator
Cardioplegia or intermittent cross-clamp fibrillation (ICCF) alone without ischaemic preconditioning
O
Outcome
Perioperative clinical outcomes including ventricular arrhythmias, inotrope requirements, and intensive care unit stayhard clinical

Ischaemic preconditioning during cardiac surgery is associated with significant reductions in perioperative ventricular arrhythmias, inotrope requirements, and ICU stay, particularly in patients receiving cardioplegia.

Main Result

Odds Ratio: 0.11 (95% CI 0.04–0.29)

p-value: p=0.001

Limitations

  • A large-scale clinical trial may be required to determine the role of ischaemic preconditioning with any certainty.
  • Numerous small trials
  • A large-scale clinical trial may be required to determine the role of IP with any certainty

Abstract

Numerous small trials have been conducted to confirm the existence of the ischaemic preconditioning (IP) mechanism in the human heart and to clarify whether it can be induced in a clinical situation. The effect on clinical end-points remains unclear. Most of the available trials reported some clinical outcomes. We performed a systematic review and meta-analysis in order to determine whether IP produces any clinical benefit in cardiac surgery. The systematic review identified 22 eligible trials containing 933 patients. All patients undergoing on-pump surgery also received cardioplegia or intermittent cross-clamp fibrillation (ICCF) with or without adjunctive cooling. IP was mainly performed after initiation of cardiopulmonary bypass, before any additional myocardial protection was initiated. Overall, IP was associated with significant reductions in ventricular arrhythmias (pooled odds ratio 0.11; 95% CI 0.04-0.29; p=0.001), inotrope requirements (pooled odds ratio 0.34; 95% CI 0.17-0.68; p=0.002) and intensive care unit stay (weighted mean difference -3h; 95% CI -4.6 to -1.5h; p=0.001). These effects persisted when the analyses were restricted to those patients receiving cardioplegia. The effect disappeared when the analyses were restricted to patients receiving ICCF. IP may provide additional myocardial protection over cardioplegia alone, but a large-scale clinical trial may be required to determine the role of IP with any certainty.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Walsh et al. (2008) conducted a meta-analysis in Cardiac surgery (n=933). Ischaemic preconditioning vs. No ischaemic preconditioning (cardioplegia or ICCF alone) was evaluated on Ventricular arrhythmias (OR 0.11, 95% CI 0.04-0.29, p=0.001). Ischaemic preconditioning during cardiac surgery significantly reduced ventricular arrhythmias (OR 0.11; 95% CI 0.04-0.29; p=0.001), inotrope requirements, and intensive care unit stay.

synapsesocial.com/papers/6a3b1f67cc8dbc104a21bbe7https://doi.org/10.1016/j.ejcts.2008.07.062
Ask AI
Helpful
Bookmark
Share
View Full Paper